Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
107,573,681
-
Number of holders
-
33
-
Total 13F shares, excl. options
-
6,463,590
-
Shares change
-
+47,284
-
Total reported value, excl. options
-
$8,987,624
-
Value change
-
-$52,721
-
Put/Call ratio
-
9.8%
-
Number of buys
-
9
-
Number of sells
-
-14
-
Price
-
$1.39
Significant Holders of VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) as of Q2 2023
44 filings reported holding VNRX - VOLITIONRX LTD - Common Stock, par value $0.001 per share as of Q2 2023.
VOLITIONRX LTD - Common Stock, par value $0.001 per share (VNRX) has 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6,463,590 shares
of 107,573,681 outstanding shares and own 6% of the company stock.
Largest 10 shareholders include Lagoda Investment Management, L.P. (3,929,110 shares), BlackRock Inc. (568,026 shares), VANGUARD GROUP INC (520,398 shares), GEODE CAPITAL MANAGEMENT, LLC (465,214 shares), MORGAN STANLEY (218,205 shares), Cowen Prime Advisors LLC (178,738 shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (176,100 shares), STATE STREET CORP (123,923 shares), NORTHERN TRUST CORP (70,092 shares), and Spectrum Asset Management, Inc. (NB/CA) (55,596 shares).
This table shows the top 33 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.